Evidence map›Paper›PMID 39455595›Full record

ArticleNature communications2024

Deletion upstream of MAB21L2 highlights the importance of evolutionarily conserved non-coding sequences for eye development.

Fabiola Ceroni, Munevver B Cicekdal, Richard Holt, Elena Sorokina, Nicolas Chassaing, Samuel Clokie, Thomas Naert, Lidiya V Talbot, Sanaa Muheisen, Dorine A Bax and 10 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Whole exome-based variant profiling and functional network characterization in neural tube defects.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Fabiola Ceroni *Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, UK.ORCID 0000-0002-7474-6361
Munevver B Cicekdal *Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.ORCID 0000-0002-1986-0815
Richard Holt *Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, UK.
Elena Sorokina *Department of Ophthalmology, Medical College of Wisconsin, Milwaukee, USA.
Nicolas ChassaingCentre de Référence des Affections Rares en Génétique Ophtalmologique CARGO, Site Constitutif, CHU Toulouse, Toulouse, France.ORCID 0000-0003-0234-8820
Samuel ClokieFaculty of Health and Life Sciences, Oxford Brookes University, Oxford, UK.
Thomas NaertDepartment of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.ORCID 0000-0003-3543-2519
Lidiya V TalbotFaculty of Health and Life Sciences, Oxford Brookes University, Oxford, UK.ORCID 0000-0002-0334-4920
Sanaa MuheisenDepartment of Ophthalmology, Medical College of Wisconsin, Milwaukee, USA.
Dorine A BaxFaculty of Health and Life Sciences, Oxford Brookes University, Oxford, UK.
Yesim KesimFaculty of Health and Life Sciences, Oxford Brookes University, Oxford, UK.
Emma C KivuvaRoyal Devon University Healthcare NHS Foundation Trust, Exeter, UK.ORCID 0000-0002-5112-3022
Catherine Vincent-DelormeService de Génétique Clinique Guy Fontaine, Hôpital Jeanne de Flandre, Lille, France.
Soeren S LienkampInstitute of Anatomy, University of Zurich, Zurich, Switzerland.ORCID 0000-0003-2963-6865
Julie PlaisanciéCentre de Référence des Affections Rares en Génétique Ophtalmologique CARGO, Site Constitutif, CHU Toulouse, Toulouse, France.ORCID 0000-0001-7551-248X
Elfride De BaereCenter for Medical Genetics, Ghent University Hospital, Ghent, Belgium.ORCID 0000-0002-5609-6895
Patrick CalvasCentre de Référence des Affections Rares en Génétique Ophtalmologique CARGO, Site Constitutif, CHU Toulouse, Toulouse, France.
Kris VleminckxDepartment of Biomedical Molecular Biology, Ghent University, Ghent, Belgium. kris.vleminckx@irc.ugent.be.ORCID 0000-0002-9666-4105
Elena V SeminaDepartment of Ophthalmology, Medical College of Wisconsin, Milwaukee, USA. esemina@mcw.edu.ORCID 0000-0003-0531-3586
Nicola K RaggeFaculty of Health and Life Sciences, Oxford Brookes University, Oxford, UK. nragge@brookes.ac.uk.ORCID 0000-0002-6122-4521

Funding

Molecular Mechanisms of Axenfeld-Rieger SyndromeR01EY015518 · NEI · MEDICAL COLLEGE OF WISCONSIN · PI Elena V Semina · 2005 to 2026
$5.6M
Genomic duplications in anophthalmia, microphthalmia and colobomaR01EY034398 · NEI · MEDICAL COLLEGE OF WISCONSIN · PI SEMINA, ELENA V · 2022 to 2025
$1.5M
MAB21L Family in Human Ocular Disease and DevelopmentR01EY025718 · NEI · MEDICAL COLLEGE OF WISCONSIN · PI SEMINA, ELENA V · 2017 to 2020
$1.4M
NEI NIH HHS R01 EY015518NEI NIH HHS R01 EY025718NEI NIH HHS R01 EY034398
6 · The paper itself

Abstract

Anophthalmia, microphthalmia and coloboma (AMC) comprise a spectrum of developmental eye disorders, accounting for approximately 20% of childhood visual impairment. While non-coding regulatory sequences are increasingly recognised as contributing to disease burden, characterising their impact on gene function and phenotype remains challenging. Furthermore, little is known of the nature and extent of their contribution to AMC phenotypes. We report two families with variants in or near MAB21L2, a gene where genetic variants are known to cause AMC in humans and animal models. The first proband, presenting with microphthalmia and coloboma, has a likely pathogenic missense variant (c.338 G > C; p.[Trp113Ser]), segregating within the family. The second individual, presenting with microphthalmia, carries an ~ 113.5 kb homozygous deletion 19.38 kb upstream of MAB21L2. Modelling of the deletion results in transient small lens and coloboma as well as midbrain anomalies in zebrafish, and microphthalmia and coloboma in Xenopus tropicalis. Using conservation analysis, we identify 15 non-coding conserved elements (CEs) within the deleted region, while ChIP-seq data from mouse embryonic stem cells demonstrates that two of these (CE13 and 14) bind Otx2, a protein with an established role in eye development. Targeted disruption of CE14 in Xenopus tropicalis recapitulates an ocular coloboma phenotype, supporting its role in eye development. Together, our data provides insights into regulatory mechanisms underlying eye development and highlights the importance of non-coding sequences as a source of genetic diagnoses in AMC.

Indexed as

ColobomaEyeMicrophthalmosPedigreeZebrafishAnimalsAnophthalmosConserved SequenceEvolution, MolecularEye ProteinsFemaleHomeodomain ProteinsHumansIntracellular Signaling Peptides and ProteinsMaleMiceEye ProteinsHomeodomain ProteinsIntracellular Signaling Peptides and ProteinsMAB21L2 protein, humanMab21l2 protein, mouseMAB21L2 protein, Xenopusmab21l2 protein, zebrafishXenopus ProteinsZebrafish Proteins

Identifiers

PMID39455595
PMCPMC11511899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.